Back
NIKE, Inc. Vs. Zenas BioPharma, Inc. Industry Stock Comparison
Sell
33
NKE
NIKE, Inc.
Last Price:
$57.36
Seasonality Move:
6.54%
Buy
60
ZBIO
Zenas BioPharma, Inc.
Last Price:
$42.83
Seasonality Move:
0.59%
Sell
33
NIKE, Inc. (NKE)
is a Sell
Is NIKE, Inc. a Buy, Sell or Hold?
-
The current NIKE, Inc. [NKE] share price is $57.34. The Score for NKE is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
NKE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Zenas BioPharma, Inc. (ZBIO)
is a Buy
Is Zenas BioPharma, Inc. a Buy, Sell or Hold?
-
The current Zenas BioPharma, Inc. [ZBIO] share price is $42.81. The Score for ZBIO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
ZBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NKE Stock Price Chart
What is NIKE, Inc.'s stock price today?
-
The NIKE, Inc. share price today is $57.34Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKE is experiencing slight buying pressure.
ZBIO Stock Price Chart
What is Zenas BioPharma, Inc.'s stock price today?
-
The Zenas BioPharma, Inc. share price today is $42.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
NKE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.19 | Sell |
| Relative Strength Index (14 RSI): | 29.93 | Sell |
| Chaikin Money Flow: | 3637231 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.08 - 66.82) | Sell |
| Bollinger Bands (100): | (63.73 - 74.55) | Sell |
ZBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.79 | Buy |
| Relative Strength Index (14 RSI): | 61.76 | Buy |
| Chaikin Money Flow: | 156273 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.4 - 40.3) | Buy |
| Bollinger Bands (100): | (17.9 - 35) | Buy |
NKE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.37 | Sell |
| 20-day SMA: | 64.38 | Sell |
| 50-day SMA: | 64.68 | Sell |
| 200-day SMA: | 67 | Sell |
| 8-day EMA: | 61.64 | Sell |
| 20-day EMA: | 63.48 | Sell |
| 50-day EMA: | 65.14 | Sell |
| 200-day EMA: | 69.18 | Sell |
ZBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.78 | Buy |
| 20-day SMA: | 38.2 | Buy |
| 50-day SMA: | 33.84 | Buy |
| 200-day SMA: | 18.39 | Buy |
| 8-day EMA: | 28.27 | Buy |
| 20-day EMA: | 15.3 | Buy |
| 50-day EMA: | 7 | Buy |
| 200-day EMA: | 1.88 | Buy |
NIKE, Inc. Earnings Growth & NKE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.40 per share, a decrease next quarter of $0.26 per share, a decrease this year of $1.58 per share, and a decrease next year of $0.58 per share.
Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.
NIKE, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zenas BioPharma, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||